Publicaciones (75) Publicaciones de María Mar Abad Hernández

2024

  1. Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide

    Biomedicine and Pharmacotherapy, Vol. 170

2023

  1. Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications

    Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257

  2. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs

    Biomedicine and Pharmacotherapy, Vol. 168

2020

  1. Alteraciones genéticas del cáncer colorrectal: implicaciones en el pronóstico y en el tratamiento de la enfermedad

    Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 9, pp. 716-721

  2. Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. MEK5 promotes lung adenocarcinoma

    The European respiratory journal

2018

  1. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: A mutational-based approach

    Oncotarget, Vol. 9, Núm. 76, pp. 34279-34288

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

  2. Genomic profile of sporadic colorectal cancer liver metastases versus primary tumors as defined by high-density microarray techniques

    Journal of Medical Discovery, Vol. 1, Núm. 1

2014

  1. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

    Oncogene, Vol. 33, Núm. 2, pp. 148-156

  2. Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

    Journal of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 648-659

  3. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer

    Medicine (United States), Vol. 93, Núm. 26

  4. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer

    Cancer, Vol. 120, Núm. 13, pp. 1948-1959

2013

  1. C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes

    Epigenetics, Vol. 8, Núm. 6

2012

  1. Multiple Novel Alternative Splicing Forms of FBXW7α Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer

    PLoS ONE, Vol. 7, Núm. 11

  2. New models towards assessing anti-cancer therapeutics

    Histology and Histopathology, Vol. 27, Núm. 2, pp. 157-170

  3. Prognostic impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas

    PLoS ONE, Vol. 7, Núm. 8

  4. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays

    Modern Pathology, Vol. 25, Núm. 4, pp. 590-601

2011

  1. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain

    APMIS, Vol. 119, Núm. 3, pp. 204-215